ATLANTA–(BUSINESS WIRE)–Two products from Axion BioSystems received New Product Awards from SLAS. Lumos and Maestro APEX, enhancements to the Maestro MEA product line, were co-winners of this award.
Medical rehabilitation bill recommended in Senate
The U.S. Senate health committee today recommended legislation to strengthen and increase the visibility of medical rehabilitation research at the NIH.The “Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act” (S. 800), sponsored by Sens. Mark Kirk, R-Ill.; Michael Bennet, D-Colo.; Orrin Hatch, R-Utah; Lisa Murkowski, R-Alaska; Johnny Isakson, R-Ga.; and Susan Collins, R-Maine, calls for the development of a comprehensive research plan at the agency to support the recovery of stroke victims and help patients return to work.
Senate committee adopts bill to facilitate genetically targeted drug development
The U.S. Senate Committee on Health, Education, Labor and Pensions adopted legislation today designed to speed up development of genetically targeted drugs for patients with rare and serious or life-threating conditions.The “Advancing Targeted Therapies for Rare Diseases Act of 2015” (S. 2030), sponsored by Sens. Michael Bennet, D-Colo., Richard Burr, R-N.C., Elizabeth Warren, D-Mass., and Orrin Hatch, R-Utah, will allow drug companies seeking approval of a candidate therapy to leverage data from previously approved drug applications and to maximize the use of certain scientific methods, such as surrogate endpoints, to (Read more...)
Publication Exclusive: Dry eye a common but still often overlooked condition
Dry eye is a problem that every ophthalmologist faces on a daily basis. It is one of the most frequent causes for patients to visit the ophthalmologist. Dry eye is a progressive disease, so the longer it goes untreated, the worse the symptoms become. D…
VIDEO: Allergan looks to have complete platform for glaucoma treatment
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Aziz Mottiwala, vice president of marketing at Allergan, discusses the company’s “franchise approach” to the glaucoma space in which it would like to ensure it has a full complement of pharmaceutical and surgical device options for treating glaucoma.
Age Related Macular Degeneration Pipeline Review, H2 2015 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/p5xgrv/age_related) has announced the addition of the “Age Related Macular Degeneration – Pipeline Review, H2 2015” report to their offering. This report provides…